In the news:
Ironically, testosterone was recently shown to reduce the incidence of atrial fibrillation, the most common kind of heart arrhythmia.
The first bellwether trial over a prescription medication used to treat low testosterone has ended in a mistrial after lead plaintiffs' attorney Christopher Seeger suffered from heart problems.
U.S. District Judge Matthew Kennelly of the Northern District of Illinois granted an oral motion made by the plaintiffs for a mistrial, according to a minute order on Monday. He scheduled a new trial in the case to begin Sept. 18.
In an email, Seeger said he would be "100 percent fine."
"I had an arrhythmia that is being treated," he wrote. "We would have been fine with a continuance but the court's schedule could not accommodate that so the case mistried [sic]."
Ironically, testosterone was recently shown to reduce the incidence of atrial fibrillation, the most common kind of heart arrhythmia.